Electro-Optical Submits MelaFind for Premarket Approval
Electro-Optical Sciences anounced that it has submitted a Premarket Approval Application to the U.S. Food and Drug Administration for MelaFind.
News
Medtronic Acquires Diabetes Tech from PreciSense
Medtronic announced at its annual investor meeting that it has acquired substantially all glucose monitoring technology from Danish company PreciSense.
Sensimed Honored With Red Herring Award
Sensimed, a Swiss company focused on the development of integrated micro-systems for medical devices, has received the Red Herring 100 Europe 2009 Award.
VIVUS Initiates Safety Study for Erectile Dysfunction Drug
Pharmaceutical company VIVUS has initiated an open label safety study of the investigational drug avanafil in males with erectile dysfunction.
Transcend Medical Raises $20 Million for Glaucoma Device
VentureWire reports that Transcend Medical, a developer of devices to treat glaucoma, has raised $20 million in equity.
[Company Profile] Vasonova
Every year, millions of U.S. patients are outfitted with a PICC line, a catheter threaded to the superior vena cava from the arm for the administration of treatments such as antibiotics or chemotherapy.
FDA Approves Ankle-Replacement System
The U.S. Food and Drug Administration has approved the Scandinavian Total Ankle Replacement (S.T.A.R.) System for patients with arthritic or deformed ankles.
Burrill Report: Financing Activity May Lift Cloud Hanging Over Biotech Industry
While biotech leaders from all over the world gathered at the 2009 BIO International Convention in Atlanta, financing activity in the sector raised hope that the cloud hanging over the industry may be lifting a little.
SyntheMed’s REPEL-CV Approved by Australian Regulators
REPEL-CV, an anti-adhesion barrier developed by biomaterials company SyntheMed, has received approval by the Australian Therapeutic Goods Administration for use in open-heart surgery.
Explore Investment and Networking Opportunities at IN3 East
Hundreds of companies such as Bain Capital Ventures, Becton Dickinson, Covidien, DePuy Mitek Worldwide, Kimberly-Clark, Medtronic, Novartis BioVenture Fund, Quaker BioVentures, Siemens Venture Capital, Stryker […]